drugset / Trial / NCT00163046

A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

NCT00163046

Phase 3 Completed 256 enrolled Viatris Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to to assess the effect of gabapentin compared to placebo on sleep, using polysomnography along with subjective sleep assessments, in subjects with transient insomnia induced by a sleep phase advance.

Timeline

Start
2005-10
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 250 mg Oral

Indications